Developmental perturbation induced by maternal asthma during pregnancy: the short- and long-term impacts on offspring

Vicki L Clifton1, Michael Davies, Vivienne Moore

  • 1Robinson Institute, University of Adelaide, Adelaide, SA 5005, Australia; Robinson Institute, University of Adelaide, Lyell McEwin Hospital, Haydown Road, Elizabeth Vale, SA 5112, Australia. vicki.clifton@adelaide.edu.au

Journal of Pregnancy
|July 26, 2012
PubMed

Insights

Maternal asthma during pregnancy can harm newborns and impact children's lifelong health. Research shows it causes placental issues and fetal development problems, particularly in females, increasing risks for conditions like diabetes and hypertension.

Area of Science:

  • Reproductive biology
  • Developmental biology
  • Perinatology

Background:

  • Maternal asthma is a common pregnancy complication.
  • Asthma in pregnancy is linked to adverse neonatal outcomes like low birthweight and preterm birth.
  • These outcomes pose risks for the lifelong health of children born to asthmatic mothers.

Purpose of the Study:

  • To investigate the impact of maternal asthma on placental function and fetal development.
  • To explore the sex-specific effects of maternal asthma on fetal development.
  • To hypothesize the long-term health risks for children of asthmatic mothers.

Main Methods:

  • Review of epidemiological studies on maternal asthma and neonatal outcomes.
  • Analysis of placental function in pregnancies complicated by asthma.
  • Assessment of fetal development and potential sex-specific alterations.

Main Results:

  • Maternal asthma induces placental dysfunction.
  • Fetal development is perturbed in a sex-specific manner due to maternal asthma.
  • These developmental changes may increase the risk of adult-onset metabolic diseases.

Conclusions:

  • Maternal asthma during pregnancy can lead to sex-specific placental and fetal developmental issues.
  • Children of asthmatic mothers, especially females, may face increased risks of lifelong health complications such as diabetes and hypertension.
  • Further research is warranted to confirm and understand these long-term health risks.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...